Back to results
US 10,596,260 B2Granted
Reoviruses having modified sequences
AssigneeOncolytics Biotech Inc.
InventorMatthew C. Coffey
Life of this patent
Estimating the term…
Abstract
The invention provides for modified reovirus nucleic acid sequences and modified reovirus polypeptide sequences as well as reoviruses containing such modified nucleic acid or polypeptide sequences. The invention also provides for pharmaceutical compositions that include reoviruses having a modified sequence as well as methods of making and using such reoviruses.
Claims19
A method of treating a proliferative disorder in a patient, comprising administering a reovirus comprising a lambda-3 polypeptide comprising SEQ ID NO:19 to the patient.
Dependencies are inferred from the claim text.